Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Cochlear ( (AU:COH) ) is now available.
Cochlear Limited has announced a change in the interests of its director, Diggory William Howitt, involving the acquisition and disposal of shares and options. The changes reflect a strategic adjustment in the director’s holdings, with implications for the company’s governance and potential market perception.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$327.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company is known for its cochlear implants, bone conduction implants, and acoustic implants, focusing on improving hearing for individuals with hearing loss.
Average Trading Volume: 175,921
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$19.66B
Learn more about COH stock on TipRanks’ Stock Analysis page.